-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Edwards Lifesciences, Raises Price Target to $100

Benzinga·12/05/2025 14:25:45
Listen to the news
RBC Capital analyst Shagun Singh maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $95 to $100.